Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rapport Therapeutics, Inc. | 159,914 | reported | 30 Mar 2026 | tx 13+373,429−32,014 |
| Cyclerion Therapeutics, Inc. | 135,000 | reported | 20 Jan 2022 | tx 2+235,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Mar 2026 | SALE | Rapport Therapeutics, Inc. | 7,161 | 28.04 USD | |
| 30 Mar 2026 | SALE | Rapport Therapeutics, Inc. | 2,839 | 28.55 USD | |
| 05 Mar 2026 | SALE | Rapport Therapeutics, Inc. | 2,014 | 28.93 USD | |
| 02 Feb 2026 | GRANT_AWARD | Rapport Therapeutics, Inc. | 132,000 | 0.00 USD | deriv |
| 26 Nov 2025 | EXERCISE | Rapport Therapeutics, Inc. | 5,000 | 1.80 USD | |
| 26 Nov 2025 | SALE | Rapport Therapeutics, Inc. | 5,000 | 30.10 USD | |
| 26 Nov 2025 | EXERCISE | Rapport Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 08 Sept 2025 | EXERCISE | Rapport Therapeutics, Inc. | 5,000 | 1.80 USD | |
| 08 Sept 2025 | SALE | Rapport Therapeutics, Inc. | 5,000 | 38.33 USD | |
| 08 Sept 2025 | EXERCISE | Rapport Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 03 Mar 2025 | GRANT_AWARD | Rapport Therapeutics, Inc. | 13,987 | 0.00 USD | |
| 03 Feb 2025 | GRANT_AWARD | Rapport Therapeutics, Inc. | 129,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Rapport Therapeutics, Inc. | 88,442 | 0.00 USD | deriv |
| 20 Jan 2022 | GRANT_AWARD | Cyclerion Therapeutics, Inc. | 135,000 | 0.00 USD | deriv |
| 09 Dec 2021 | GRANT_AWARD | Cyclerion Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |